Silo Pharma, Inc. (NASDAQ:SILO – Get Free Report) saw a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 134,100 shares, a decrease of 25.4% from the August 15th total of 179,700 shares. Based on an average daily volume of 5,040,000 shares, the short-interest ratio is presently 0.0 days. Approximately 3.1% of the shares of the company are sold short.
Silo Pharma Stock Performance
Shares of SILO stock opened at $1.11 on Monday. Silo Pharma has a 12-month low of $0.84 and a 12-month high of $4.50. The firm’s 50 day moving average is $1.53 and its 200 day moving average is $1.62.
Silo Pharma (NASDAQ:SILO – Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($0.31) earnings per share (EPS) for the quarter. The firm had revenue of $0.02 million during the quarter. Silo Pharma had a negative return on equity of 55.30% and a negative net margin of 4,881.57%.
Silo Pharma Company Profile
Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.
See Also
- Five stocks we like better than Silo Pharma
- What is an Earnings Surprise?
- Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity
- With Risk Tolerance, One Size Does Not Fit All
- 3 Undervalued Stocks That Are Too Cheap to Ignore Right Now
- The 3 Best Blue-Chip Stocks to Buy Now
- The Analyst Edge: How to Use Expert Opinions
Receive News & Ratings for Silo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
